NuSirt Biopharma, Inc. has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.

The company has protected the discovery and application of this broad based technology platform through an extensive IP portfolio that includes two issued patents and thirteen active patent applications. NuSirt has successfully conducted multiple clinical studies that have validated its discovery and demonstrated the value of its intellectual property.

Learn More

Call 615-810-8191

Or Request more information.


NuSirt News

Phase 2A, Type 2 diabetes study enrollment nearing completion.

 

See All News

Contact

3835 Cleghorn Avenue, Suite 200
Nashville, TN 37215
615-810-8191